Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  01/18/2012
 
Trade Name:  Viread
 
Generic or Proper Name (*):  tenofovir disoproxil fumarate
 
Indications Studied:  Treatment of HIV infection in combination with other antiretroviral agents
 
Therapeutic Category:  Antiviral
 
Ages Studied:  2 - <12 years
 
Study #:  2
 
Study Type:  Safety/Pharmacokinetic
 
Study Design:  Open Label/Traditional Pharmacokinetic
 
No Patients:  32
 
No Centers:  1
 
No Countries:  1
 
BPCA(B), PREA(P):  B,P
 
White:  26
 
Native Hawaiian or Pacific Islander:  1
 
-
-